title: Patient care--who pays, and for what?
abstract: Economic considerations are increasingly affecting treatment strategies, particularly in illnesses such as schizophrenia, which have high degrees of morbidity and chronicity. Restrictions on the availability of public-sector hospitalization have produced increased pressure for shorter stays and more reliance on outpatient treatment. In turn, financial constraints are operative in both public- and private-sector outpatient care. Effective psychopharmacology, which involves facilitation of patient compliance, is essential to the cost-effective treatment of schizophrenic patients in the current economic climate.
mesh_terms: D000553:Ambulatory Care / Q000191:economics; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000191:economics*; D004470:Economics, Medical; D006291:Health Policy; D006760:Hospitalization / Q000191:economics; D006801:Humans; D008605:Mental Health Services / Q000191:economics; D009820:Ohio; D010349:Patient Compliance; D011613:Psychotherapy / Q000191:economics; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*
chemical_list: D014150:Antipsychotic Agents